Opioids - Are the Blind Leading the Blind?
Two attendance options:
DMU faculty, staff, students, residents, and the medical community.
According to the Iowa Department of Public Health, 2017 was Iowa's highest year for opioid deaths, up nearly 900% from 2000. The good news is that the number of deaths involving opioids from January to August of 2018 has fallen 35% from 2017. However, there is still much work to be done.
- Discuss the recent history of narcotic use in the United States.
- Construct a mental model for compassionate care and solution-focused treatment of opioid abusers.
- Identify treatment options for opioid addicted persons.
- Discuss the point-of-view of addicted persons and their caregivers in providing patient-centered care.
- AOA: Joint Principles on Opioid Crisis Call for Comprehensive, Public Health Approach to Addiction Treatment
- AMA: Reversing the Opioid Epidemic
- Dealers, Doctors, and the Drug Company that Addicted America by Beth Macy, Book Video
- Rural Communities Fight with the Struggle Against the Opioid Epidemic
- Surviving Bad Episodes From 2018, 2017, 2016
- Opiod Battle Turns Corner
Des Moines University is located on a 22-acre campus in the heart of Des Moines, Iowa. Just west of downtown on Grand Avenue, the University is located in one of Des Moines' most prestigious neighborhoods. The campus is in a historic neighborhood filled with tree-lined streets and gracious older homes and businesses. Its central location makes it easy to access the rest of the city and outlying communities. The campus is close to the Des Moines International Airport, located on the bus line and just blocks from local shopping and downtown Des Moines.
Thomas Benzoni, DO, EM, AOBEM, FACEP
Assistant Professor, Family Medicine, Des Moines University
President and Executive Director, The Partnership for a Drug Free Iowa
Mr. Komendowski has over 12 years of experience managing a task force made up of substance abuse prevention, public safety, public policy, public health, health care, education and business interests focused on identifying and mitigating the factors influencing youth high-risk behavior. He has most recently been heavily involved in media, community outreach and educational forums focused on the epidemiology of the opioid crisis and community health improvement initiatives.
Relevant to the content of this educational activity, the speakers indicated they have no financial relationships with commercial interest companies to disclose.
Continuing Education Credit
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this live activity for 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- DPM: Des Moines University (DMU) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. DMU has approved this activity for a maximum of 1.0 continuing education contact hours.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.
- Other healthcare providers: This live activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.
No commercial interest provided financial support for this continuing education activity.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 1A
- 1.00 CE Contact Hour(s)
- 1.00 CPME
- 1.00 IBON